The CARESS consortium consisting of 3 RTD performers (CNR, ICO, LABOR) and 4 SME's (IRBM, ODPM, OPTO, AMEDA) combines comprehensive research capabilities and scientific competences with long-term experience in manufacturing and commercialization.

The complimentary skills of the consortium members and their commit-ment to the project aim are a solid basis to ensure that the project output

will provide the intended contribution to an improvement of cancer therapy for the sake of patients all around the world.

A detailed project management plan has been set up defining different work packages specifying the tasks of each consortium member and defining communication structures to ensure efficient collabroation of the consortium members from different parts of Europe.

The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013), managed by the REA - Research Executive Agency under the Grant Agreement n° 315398